Eli Lilly and Co
NYSE:LLY

Watchlist Manager
Eli Lilly and Co Logo
Eli Lilly and Co
NYSE:LLY
Watchlist
Price: 786.23 USD -3.15% Market Closed
Market Cap: 747.3B USD
Have any thoughts about
Eli Lilly and Co?
Write Note

Eli Lilly and Co
Accrued Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Eli Lilly and Co
Accrued Liabilities Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
ZTS

Competitive Accrued Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Accrued Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Eli Lilly and Co
NYSE:LLY
Accrued Liabilities
$14.1B
CAGR 3-Years
21%
CAGR 5-Years
19%
CAGR 10-Years
18%
Johnson & Johnson
NYSE:JNJ
Accrued Liabilities
$33.5B
CAGR 3-Years
4%
CAGR 5-Years
8%
CAGR 10-Years
10%
Bristol-Myers Squibb Co
NYSE:BMY
Accrued Liabilities
$13.3B
CAGR 3-Years
10%
CAGR 5-Years
16%
CAGR 10-Years
15%
Pfizer Inc
NYSE:PFE
Accrued Liabilities
$2.6B
CAGR 3-Years
0%
CAGR 5-Years
-1%
CAGR 10-Years
3%
Merck & Co Inc
NYSE:MRK
Accrued Liabilities
$15.7B
CAGR 3-Years
3%
CAGR 5-Years
6%
CAGR 10-Years
5%
Zoetis Inc
NYSE:ZTS
Accrued Liabilities
$1.1B
CAGR 3-Years
4%
CAGR 5-Years
9%
CAGR 10-Years
18%

See Also

What is Eli Lilly and Co's Accrued Liabilities?
Accrued Liabilities
14.1B USD

Based on the financial report for Sep 30, 2024, Eli Lilly and Co's Accrued Liabilities amounts to 14.1B USD.

What is Eli Lilly and Co's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 10Y
18%

Over the last year, the Accrued Liabilities growth was 11%. The average annual Accrued Liabilities growth rates for Eli Lilly and Co have been 21% over the past three years , 19% over the past five years , and 18% over the past ten years .

Back to Top